These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29499765)

  • 1. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    EBioMedicine; 2018 Aug; 34():35-45. PubMed ID: 30037719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 7. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
    Zuo C; Li X; Huang J; Chen D; Ji K; Yang Y; Xu T; Zhu D; Yan C; Gao P
    Cardiovasc Res; 2018 Apr; 114(5):703-712. PubMed ID: 29415171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
    Wang Y; Wu Z; Hu L
    Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.
    Chen H; Liu Y; Jiang CJ; Chen YM; Li H; Liu QA
    Med Sci Monit; 2019 Jun; 25():4176-4185. PubMed ID: 31164625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-1290/OGN axis in ovarian cancer-associated fibroblasts modulates cancer cell proliferation and invasion.
    Jiang B; Xiao S; Zhang S; Xiao F
    J Ovarian Res; 2024 Feb; 17(1):52. PubMed ID: 38402185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
    Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
    Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.
    Xu T; Zhang R; Dong M; Zhang Z; Li H; Zhan C; Li X
    Onco Targets Ther; 2019; 12():10639-10650. PubMed ID: 31824171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells.
    Suman S; Das TP; Sirimulla S; Alatassi H; Ankem MK; Damodaran C
    Oncotarget; 2016 Mar; 7(12):13854-64. PubMed ID: 26883103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial-mesenchymal transformation in a mouse model of myocarditis.
    Fang Y; Chang Z; Xu Z; Hu J; Zhou H; Yu S; Wan X
    Biofactors; 2020 Nov; 46(6):1018-1030. PubMed ID: 33141515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.